Boston Scientific Files 8-K on Financials
Ticker: BSX · Form: 8-K · Filed: Oct 22, 2025 · CIK: 885725
| Field | Detail |
|---|---|
| Company | Boston Scientific CORP (BSX) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: BSX
TL;DR
BSX filed an 8-K on Oct 22, 2025, covering financial results and condition.
AI Summary
Boston Scientific Corporation filed an 8-K on October 22, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing details information related to its common stock and senior notes due in 2027.
Why It Matters
This filing provides investors with updated information on Boston Scientific's financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Boston Scientific Corporation (company) — Registrant
- October 22, 2025 (date) — Filing Date
- 300 Boston Scientific Way, Marlborough, Massachusetts (address) — Business Address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Boston Scientific Corporation's results of operations and financial condition, along with financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on October 22, 2025.
What are the key financial items mentioned in the filing?
The filing mentions items related to common stock and senior notes due in 2027.
Where is Boston Scientific Corporation headquartered?
Boston Scientific Corporation is headquartered at 300 Boston Scientific Way, Marlborough, Massachusetts.
What is Boston Scientific Corporation's fiscal year end?
Boston Scientific Corporation's fiscal year ends on December 31.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-10-22 06:32:46
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share BSX New York Stock
Filing Documents
- bsx-20251022.htm (8-K) — 27KB
- q32025earningsrelease.htm (EX-99.1) — 350KB
- image.jpg (GRAPHIC) — 37KB
- 0000885725-25-000046.txt ( ) — 606KB
- bsx-20251022.xsd (EX-101.SCH) — 3KB
- bsx-20251022_def.xml (EX-101.DEF) — 15KB
- bsx-20251022_lab.xml (EX-101.LAB) — 27KB
- bsx-20251022_pre.xml (EX-101.PRE) — 16KB
- bsx-20251022_htm.xml (XML) — 4KB
02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On October 22, 2025, Boston Scientific Corporation issued a press release announcing financial results for the third quarter ended September 30, 2025. A copy of the release is furnished with this report as Exhibit 99.1. The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
01. FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Boston Scientific Corporation dated October 22, 2025 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 22, 2025 BOSTON SCIENTIFIC CORPORATION By: /s/ Susan Thompson Susan Thompson Vice President, Chief Corporate Counsel and Assistant Secretary